Article
AAV-Mediated <i>In Vivo</i> CAR Gene Therapy for Targeting Human T Cell Leukemia
2021-02-15
Abstract excerpt
Chimeric antigen receptor (CAR) T cell therapy is the most active field in immuno-oncology and brings substantial benefit to patients with B cell malignancies. However, the complex procedure for CAR T cell generation hampers its widespread applications. Here, we describe a novel approach in which human CAR T cells can be generated within the host upon injecting an Adeno-associated virus (AAV)vector carrying the CA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a64cbd78-7cef-5c83-8c4f-6fb3bac43c0c
- DOI
- 10.1101/2021.02.15.431201
